Doalis is a senior-level strategic advisory platform founded by Faik Somer and Bahadır Özazar, drawing on their combined senior leadership experience across global pharmaceutical markets, and focused on value creation for pharmaceutical companies operating in complex, global environments.

Doalis is a senior-level strategic advisory platform focused on value creation for pharmaceutical companies operating across complex global environments.

We support shareholders, boards, and executive leadership at moments where portfolio decisions, capital allocation, and strategic transactions directly impact enterprise value.

Doalis operates outside traditional consulting models.

We focus on strategic clarity, capital discipline, and measurable outcomes.

The pharmaceutical industry is no longer challenged by growth alone.
It is challenged by focus, coherence, and capital discipline.

Doalis works with pharmaceutical leaders at moments where strategic decisions are irreversible and value-defining.

Portfolio clarity.
Capital efficiency.
Cross-border coherence.

Doalis helps companies make fewer decisions — and make them count.

DOALIS STRATEGY

Org chart

Teams

Offices